XTL Biopharmaceuticals Ltd (XTLB) — Financial Flexibility Index
XTL Biopharmaceuticals Ltd (XTLB) has a Financial Flexibility Index of -0.10x as of December 2017. Free cash flow of ILA-301.00K (operating CF ILA-301.00K minus capex ILA0.00) represents 0% of total liabilities (ILA2.97 Million). Check XTL Biopharmaceuticals Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
XTL Biopharmaceuticals Ltd Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for XTL Biopharmaceuticals Ltd across 12 annual periods. See XTL Biopharmaceuticals Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for XTL Biopharmaceuticals Ltd (2013–2024)
Year-by-year free cash flow to debt coverage for XTL Biopharmaceuticals Ltd. For the full company profile including market capitalisation, see market value of XTL Biopharmaceuticals Ltd.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.50x | ILA-1.56 Million | ILA-1.62 Million | ILA3.12 Million | ▲ +85.4% |
| 2023 | -3.43x | ILA-707.00K | ILA-707.00K | ILA206.00K | ▲ +28.8% |
| 2022 | -4.82x | ILA-901.00K | ILA-901.00K | ILA187.00K | ▼ -490.2% |
| 2021 | -0.82x | ILA-1.05 Million | ILA-1.05 Million | ILA1.28 Million | ▲ +75.6% |
| 2020 | -3.34x | ILA-849.00K | ILA-850.00K | ILA254.00K | ▲ +14.4% |
| 2019 | -3.91x | ILA-906.00K | ILA-908.00K | ILA232.00K | ▼ -21.4% |
| 2018 | -3.22x | ILA-814.00K | ILA-816.00K | ILA253.00K | ▼ -750.0% |
| 2017 | -0.38x | ILA-1.12 Million | ILA-1.12 Million | ILA2.97 Million | ▲ +92.8% |
| 2016 | -5.24x | ILA-1.73 Million | ILA-1.73 Million | ILA330.00K | ▼ -23.0% |
| 2015 | -4.26x | ILA-1.86 Million | ILA-1.86 Million | ILA436.00K | ▼ -67.1% |
| 2014 | -2.55x | ILA-2.46 Million | ILA-2.47 Million | ILA965.00K | ▼ -29.9% |
| 2013 | -1.96x | ILA-2.42 Million | ILA-2.50 Million | ILA1.23 Million | — |